摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

士的宁半硫酸盐 | 60-41-3

中文名称
士的宁半硫酸盐
中文别名
马钱子碱硫酸盐;硫酸马钱子碱五水化合物;硫酸士的宁
英文名称
(-)-strychninium sulfate
英文别名
strychnine hemisulfate;strychninium sulfate;strychnine sulfate;(4aR,5aS,8aR,13aS,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one;sulfuric acid
士的宁半硫酸盐化学式
CAS
60-41-3
化学式
2C21H23N2O2*O4S
mdl
——
分子量
766.915
InChiKey
SQZRGLKZOYHTRV-ZEYGOCRCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    284-286 °C(lit.)
  • 密度:
    1.0926 (rough estimate)
  • 溶解度:
    可溶于氯仿,清澈到浑浊

计算性质

  • 辛醇/水分配系数(LogP):
    1.44
  • 重原子数:
    30
  • 可旋转键数:
    0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    116
  • 氢给体数:
    2
  • 氢受体数:
    7

ADMET

毒理性
  • 暴露途径
该物质可以通过吸入其气溶胶和通过摄入被身体吸收。
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 吸入症状
见摄取。
See Ingestion.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 摄入症状
抽搐。肌肉僵硬。休克或晕厥。
Convulsions. Muscle stiffness. Shock or collapse.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)

安全信息

  • 危险等级:
    6.1(a)
  • 危险品标志:
    T+,N
  • 安全说明:
    S13,S28,S36/37,S45,S60,S61
  • 危险类别码:
    R27/28,R50/53,R26/28
  • WGK Germany:
    3
  • RTECS号:
    WL2550000
  • 包装等级:
    I
  • 危险类别:
    6.1(a)
  • 危险品运输编号:
    UN 1692 6.1/PG 1

SDS

SDS:0f9f5a576a321909940c7a2e34812b8f
查看

Section 1. Chemical Product and Company Identification
Strychnine Hemisulfate
Common Name/
Trade Name
Manufacturer
Commercial Name(s)
Synonym
Chemical Name
Chemical Family
Strychnine Hemisulfate

Section 4. First Aid Measures
Eye Contact Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops.
Cold water may be used.
Serious Skin Contact Not available.
Inhalation If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention.
Serious Inhalation Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth
resuscitation. Seek medical attention.
Ingestion If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by
mouth to an unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical
attention immediately.
Serious Ingestion Not available.

Section 5. Fire and Explosion Data
Flammability of the Product Non-flammable.
Auto-Ignition Temperature Not applicable.
Flash Points Not applicable.
Flammable Limits Not applicable.
Products of Combustion Not available.
Fire Hazards in Presence of Not applicable.
Various Substances
Explosion Hazards in Presence Risks of explosion of the product in presence of mechanical impact: Not available.
of Various Substances Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media Not applicable.
and Instructions
Special Remarks on Not available.
Fire Hazards
Special Remarks on Explosion Not available.
Hazards

Section 6. Accidental Release Measures
Small Spill Use appropriate tools to put the spilled solid in a convenient waste disposal container.
Large Spill
Poisonous solid.
Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray to
disposal.
Strychnine Hemisulfate

Section 7. Handling and Storage
Precautions Do not ingest. Do not breathe dust. Wear suitable protective clothing. In case of insufficient ventilation, wear
suitable respiratory equipment. If ingested, seek medical advice immediately and show the container or the label.
Keep away from incompatibles such as acids, alkalis.
Storage Keep container tightly closed. Keep container in a cool, well-ventilated area.

Section 8. Exposure Controls/Personal Protection
Engineering Controls Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
a Large Spill to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits Not available.

Section 9. Physical and Chemical Properties
Physical state and appearance Solid. (Powdered solid.) Odor Not available.
Taste Bitter.
Molecular Weight 383.5 g/mole
Color Off-white.
pH (1% soln/water) Not available.
Not available.
Boiling Point
Melting Point Not available.
Not available.
Critical Temperature
Specific Gravity Not available.
Vapor Pressure Not applicable.
Vapor Density Not available.
Volatility Not available.
Odor Threshold Not available.
Water/Oil Dist. Coeff. Not available.
Ionicity (in Water) Not available.
Dispersion Properties See solubility in water.
Solubility Soluble in cold water.

Section 10. Stability and Reactivity Data
The product is stable.
Stability
Instability Temperature Not available.
Conditions of Instability Excess heat, incompatible materials, dust generation
Reactive with acids, alkalis.
Incompatibility with various
substances
Not available.
Corrosivity
Strychnine Hemisulfate
Incompatible with alkalies, alkali carbonates, bicarbonates, benzoates, dichromates, bromides, iodides, tannic and
Special Remarks on
Reactivity picric acids, salicylates, borax, gold chlorides, piperazine.
Not available.
Special Remarks on
Corrosivity
Polymerization Will not occur.

Section 11. Toxicological Information
Routes of Entry Inhalation. Ingestion.
Toxicity to Animals Acute oral toxicity (LD50): 2.6 mg/kg [Rat].
Chronic Effects on Humans Not available.
Other Toxic Effects on Very hazardous in case of ingestion, of inhalation.
Humans Slightly hazardous in case of skin contact (irritant).
Special Remarks on Not available.
Toxicity to Animals
Special Remarks on Not available.
Chronic Effects on Humans
Special Remarks on other Acute Potential Health Effects:
Toxic Effects on Humans Skin: May cause skin irritation.
Eyes: May cause eye irritation.
Inhalation: Inhalation of dust or fumes (when heated to decompositioni) can result in respiratory tract irritation with
chemical pneumonitis, bronchospasm, or noncardiogenic pulmonary edema. It is rapidly absorbed from the
respiratory tract, and intranasally resulting in toxicity within 30 minutes.
Ingestion: May be fatal if swallowed. It is rapidly absorbed from the gastrointestinal tract.
Styrchnine poisoning causes nausea, vomiting, and profuse diarrhea. It can affect the cardiovascular system,
respiration, behavior/central nevrous system, blood and brain. It is a central nervous system stimulant which can
cause severe headaches, and tonic convulsions. A prodromal syndrome including muscular cramps, stiffness,
and agitation is commonly reported prior to the onset of convulsions; generalized convulsions may be the initial
event. Generalized convulsions usually occur within 15 to 60 minutes after acute ingestion and within 30 minutes
after being absorbe from the respiratory tract. Hypothermia (low body temperature), hypotension (low blood
pressure), and hypertension (high blood pressure) have been noted in Strychnine poisoning. Hypotension
appears to be due to marked acidosis and hypoxia in individuals with severe poisoning. Severe and prolonged
convulsions may result in marked hyperthermia (high body temperature). Temperatures as high as 43 C. have
been reported. Bilateral horizontal pendular nystagmus (involuntary eye movement) may occur. Bradycardia
(slow heartbeat) can be associated with hypotension and tachycardia (fast heartbeat) as well as tachypena (fast,
shallow breathing)commonly accompanies agitation and neuromuscular hyperactivity. The affected individual may
complain of chest tightness, difficulty breathing, and a feeling of suffocation. Cardiac arrest may result from
severe or prolonged convulsions or respiratory arrest. With severe or prolonged convulsions, sustained
contractions of the chest wall muscles and diaphragm may lead to respiratory paralysis. A period of flaccid
paralysis with apnea (no breathing) and cyanosis (bluish discoloration) may also occur after the period of
convulsions. Renal failure, rapid breakdown of skeletal muscle tissue (Rhabdomyolysis), multiple organ failure
(including liver necrosis) may also occur. Death is usually due to respiratory failure.

Section 12. Ecological Information
Not available.
Ecotoxicity
BOD5 and COD Not available.
Products of Biodegradation Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products The products of degradation are less toxic than the product itself.
of Biodegradation
Special Remarks on the Not available.
Products of Biodegradation
Strychnine Hemisulfate

Section 13. Disposal Considerations
Waste Disposal Waste must be disposed of in accordance with federal, state and local environmental
control regulations.

Section 14. Transport Information
DOT Classification CLASS 6.1: Poisonous material.
: Strychnine salt (styrchnine hemisulfate) UNNA: 1692 PG: I
Identification
Not available.
Special Provisions for
Transport
DOT (Pictograms)

Section 15. Other Regulatory Information and Pictograms
Illinois toxic substances disclosure to employee act: Strychnine Hemisulfate
Federal and State
Illinois chemical safety act: Strychnine Hemisulfate
Regulations
New York release reporting list: Strychnine Hemisulfate
Pennsylvania RTK: Strychnine Hemisulfate
Massachusetts RTK: Strychnine Hemisulfate
Massachusetts spill list: Strychnine Hemisulfate
New Jersey: Strychnine Hemisulfate
New Jersey spill list: Strychnine Hemisulfate
Louisiana RTK reporting list: Strychnine Hemisulfate
SARA 302/304/311/312 extremely hazardous substances: Strychnine Hemisulfate
CERCLA: Hazardous substances.: Strychnine Hemisulfate: 10 lbs. (4.536 kg)
California California prop. 65: This product contains the following ingredients for which the State of California has found
Proposition 65 to cause cancer which would require a warning under the statute: No products were found.
Warnings
California prop. 65: This product contains the following ingredients for which the State of California has found
to cause birth defects which would require a warning under the statute: No products were found.
Other Regulations OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances (EINECS No.
200-47-7).
Canada: Not listed on Canadian Domestic Substance List (DSL) or Canadian Non-Domestic Substances List
(NDSL)
China: Not listed on National Inventory.
Japan: Not listed on National Inventory (ENCS).
Korea: Not listed on National Inventory (KECI).
Philippines: Not listed on National Inventory (PICCS).
Australia: Not listed on AICS.
WHMIS (Canada) CLASS D-1A: Material causing immediate and serious toxic effects (VERY TOXIC).
Other Classifications
DSCL (EEC) R28- Very toxic if swallowed. S28- After contact with skin, wash immediately
with plenty of [***]
S36/37- Wear suitable protective clothing and
gloves.
S45- In case of accident or if you feel unwell,
seek medical advice immediately (show the
label where possible).
Strychnine Hemisulfate
Health Hazard
HMIS (U.S.A.) 3 National Fire Protection
0 Flammability
0 Association (U.S.A.)
Fire Hazard
3 0 Reactivity
Health
Reactivity
0
Specific hazard
Personal Protection
E
WHMIS (Canada)
(Pictograms)
DSCL (Europe)
(Pictograms)
TDG (Canada)
(Pictograms)
ADR (Europe)
(Pictograms)
Protective Equipment
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Safety glasses.


SECTION 16 - ADDITIONAL INFORMATION
N/A





制备方法与用途

类别:有毒物品

毒性分级:剧毒

急性毒性:

  • 口服-大鼠 LD50: 2.6 毫克/公斤
  • 口服-小鼠 LDL0: 8 毫克/公斤

可燃性危险特性:不易燃;燃烧时产生有毒的氧化氮气体

储运特性:应存放在通风、低温和干燥的库房中,并与食品分开储存和运输

灭火剂:可用、泡沫、二氧化碳或砂土进行灭火

反应信息

  • 作为反应物:
    描述:
    sodium hexachloroosmate(IV) 、 士的宁半硫酸盐 生成
    参考文献:
    名称:
    THE QUANTITATIVE DETERMINATION OF OSMIUM BY MEANS OF STRYCHNINE SULFATE1
    摘要:
    DOI:
    10.1021/ja01364a007
点击查看最新优质反应信息

文献信息

  • [EN] HYDROXYLATED TRICYCLIC COMPOUNDS<br/>[FR] COMPOSÉS TRICYCLIQUES HYDROXYLÉS
    申请人:NEKTAR THERAPEUTICS
    公开号:WO2012079017A1
    公开(公告)日:2012-06-14
    The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.
    这项发明提供了通过共价连接溶性寡聚体进行化学修饰的小分子药物。根据本发明的化合物,当通过多种给药途径之一给予时,表现出与未连接溶性寡聚体的小分子药物不同的特性。
  • Oligomer-Aryloxy-Substituted Propanamine Conjugates
    申请人:Riggs-Sauthier Jennifer
    公开号:US20110071207A1
    公开(公告)日:2011-03-24
    The invention relates to (among other things) oligomer-aryloxy-substituted propanamine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated aryloxy-substituted propanamine compounds.
    该发明涉及寡聚物-芳氧基取代的丙胺酰共轭物和相关化合物(除其他外)。该发明的共轭物在通过任何一种给药途径给予时,表现出优于未共轭的芳氧基取代的丙胺酰化合物的优点。
  • Hydroxylated Tricyclic Compounds
    申请人:Riggs-Sauthier Jennifer
    公开号:US20130317114A1
    公开(公告)日:2013-11-28
    The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.
    该发明提供了通过共价连接溶性寡聚物对小分子药物进行化学修饰的小分子药物。该发明的化合物,在通过多种给药途径任何一种给药时,表现出与未连接溶性寡聚物的小分子药物不同的特性。
  • OLIGOMER-TRICYCLIC CONJUGATES
    申请人:NEKTAR THERAPEUTICS
    公开号:US20140100268A1
    公开(公告)日:2014-04-10
    The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.
    该发明提供了通过共价结合溶性寡聚物对化学修饰的小分子药物。该发明的结合物,在通过多种给药途径任何一种给药时,表现出与未与溶性寡聚物结合的小分子药物不同的特征。
  • New derivatives of alpha-amino-gamma-butyrolactone, method for the preparation thereof and pharmaceutical compositions containing them
    申请人:Laboratorio Farmaceutico C.T. s.r.l.
    公开号:EP0151964A2
    公开(公告)日:1985-08-21
    The present invention relates to new derivatives of α-amino-γ-butyrolactone and their pharmaceutically acceptable salts, endowed with anti-convulsant, anti-epileptic, sedative action and able to inhibit the ingestion of alcohol and intoxicating drinks. The invention relates also to the method for preparing the derivatives of the invention as well as the pharmaceutical compositions containing them.
    本发明涉及α-基-γ-丁内酯的新衍生物及其药学上可接受的盐类,具有抗惊厥、抗癫痫和镇静作用,并能抑制酒精和醉酒饮料的摄入。 本发明还涉及本发明衍生物的制备方法以及含有这些衍生物的药物组合物。
查看更多

同类化合物

马钱子碱 馬錢子鹼硝酸鹽 达波灵碱 葫芦素 荧光箭毒素氯化物 缝籽碱 箭头毒 V 磷酸士的宁 硫酸白路新 硫酸二甲基马钱子碱酯七水合物 硝酸士的宁 盐酸士的宁 盐酸士的宁 白路新硫酸盐 白坚木亭 番木鳖碱硫酸盐五水合物 番木鳖碱砷酸盐 番木鳖碱盐酸盐二水合物 番木鳖碱二甲基次胂酸盐 番木鳖碱N-氧化物水合物 番木鳖碱-N-氧化物 番木鳖碱 甘油磷酸士的宁 托锡弗林 异士的宁 士的宁半硫酸盐 土波台文碱N-氧化物 土波台文碱 去甲氟箭毒素 去乙酰基达波灵碱 N-甲基番木鳖碱 C-箭毒碱III Alpha-可鲁勃林 4-羟基士的宁-10-酮 2H-吡喃-4-胺,四氢-2,2-二甲基-N-(2-噻嗯基亚甲基)- 21,22-二氢番木鳖碱-10-酮 21,22-二氢-21,22-二羟基番木鳖碱-10-酮 2-硝基士的宁-10-酮 2,3-二甲氧基士的宁 19-甲基番木鳖碱-19-鎓氯化物 16-羟基-2,3-二甲氧基士的宁-10-酮 16-甲氧基士的宁-10-酮 16-(1-甲基乙氧基)番木鳖碱-10-酮 12H-1,12-乙基桥-9H,11H-[1,3]氧杂联氮基[3,4,5-lm]吡咯并[2,3-d]咔唑-9-乙酚,14-乙基-b-[(2R,3E,12bS)-3-亚乙基-1,2,3,4,6,7,12,12b-八氢吲哚并[2,3-a]喹嗪-2-基]-2,3,11a,11b,13,13a-六氢-,(bS,1S,3aR,9S,11aS,11bS,12S,13aS,14S)-(9CI) 12,13-二去氢-2,3-二甲氧基-12,24-开环士的宁-10-酮 (19S)-2,16-二去氢-19-羟基-枯苒-17-酸甲酯 (19E)-2,16,19,20-四去氢枯苒-17-酸甲酯 (19E)-1-乙酰基-19,20-二去氢-枯苒-17-醇 (17S)-1-乙酰基-19,20-二去氢-17,18-环氧-11-甲氧基枯苒-17-醇乙酸酯 19-methoxy-2,17-dioxo-17,18-cyclo-corynox-18-ene-16-carboxylic acid methyl ester